Skip to main content

Peer Review reports

From: Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies

Original Submission
8 Mar 2019 Submitted Original manuscript
27 Jan 2020 Author responded Author comments - Xinan Sheng
28 Feb 2020 Author responded Author comments - Xinan Sheng
28 Sep 2019 Reviewed Reviewer Report - Manuela Schmidinger
12 Dec 2019 Reviewed Reviewer Report - Reviewer 2
22 Feb 2020 Reviewed Reviewer Report - Manuela Schmidinger
Resubmission - Version 2
27 Jan 2020 Submitted Manuscript version 2
Publishing
3 Mar 2020 Editorially accepted
14 Mar 2020 Article published 10.1186/s12885-020-6708-8

You can find further information about peer review here.

Back to article page
\